Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2020 | Story Lacea Loader

Update: 26 January 2020
Bloemfontein Campus registration process to continue on Monday 27 January 2020


The registration process for students on the Bloemfontein Campus of the University of the Free State (UFS) will continue on Monday 27 January 2020 as per the registration programme.

First-year students who have not registered must refer to their email, the university’s self-service portal, and the Call Centre (051 401 9666) for information. Senior students can visit registration venues on campus if they require academic advice.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



Update: 24 January 2020
Bloemfontein Campus registration process not to continue the afternoon of Friday 24 January 2020  


The first-year registration process on the Bloemfontein Campus will not continue after 13:00 today (Friday 24 January 2020), but will resume on Monday 27 January 2020.

This decision taken by the executive management of the university comes after a number of students disrupted the registration process this morning and prevented first-year students to enter registration venues.

Constant engagements with the Institutional Student Representative Council (ISRC) and the Student Representative Council (SRC) of the Bloemfontein Campus have taken place since the beginning of the year regarding matters of concern to students, and the executive management will continue to do so. The university management is disappointed with this morning’s disruptive behaviour led by the Bloemfontein Campus SRC, despite these regular engagements.

The situation on the campus is being closely monitored by the university’s Protection Services and the South African Police Service.

 

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept